Research and Reviews in the Fastlane 098

This study compared appropriate doses for PCC (bebulin) vs. FFP (10ml/kg) vs. FFP+PCC. All patients received Vit K. There were no differences between PCC and FFP related to time to correct INR or vascular complications. Interestingly there was a significantly lower rate of death and re-bleed on the PCC group. The expected difference on speed of correction was not seen by the outcomes were significantly better with PCC, is it time to adopt it as standard of care? Recommended by: Daniel Cabrera Emergency Medicine Beam DM et al. Immediate Discharge and Home Treatment With Rivaroxaban of Low-risk Venous Thromboembolism Diagnosed in Two U.S. Emergency Departments: A One-year Preplanned Analysis. Acad Emerg Med 2015. PMID: 26113241 This study provides us with more evidence that in a appropriately selected low risk patient population with VTE, and close follow up, outpatient anticoagulation with Rivaroxaban is feasible with very low rate of recurrence of VTE and risk of bleeding while on therapy. Recommended by: Salim R. Rezaie Toxicology Wei YB et al. Genitourinary toxicity of ketamine. Hong Kong Med J 2013; 19(4):341-8. PMID: 23832948. Something to look out for – those who abuse ketamine for long enough often end up with bladder issues. Ulcerative cystitis is common. Stopping the ketamine works for some but for a lot of people there’s some permanent dysfunction. Keep it in mind. It turns out there are somethings you can’t fix with ketamine. Recommended by: An...
Source: Life in the Fast Lane - Category: Emergency Medicine Authors: Tags: Education Emergency Medicine Emergency Medicine Update Haematology Intensive Care Laboratory R&R in the FASTLANE Renal Toxicology and Toxinology Urology EBM literature research and reviews Source Type: blogs